236 related articles for article (PubMed ID: 19122176)
1. The antiangiogenic activity of rPAI-1(23) inhibits vasa vasorum and growth of atherosclerotic plaque.
Drinane M; Mollmark J; Zagorchev L; Moodie K; Sun B; Hall A; Shipman S; Morganelli P; Simons M; Mulligan-Kehoe MJ
Circ Res; 2009 Feb; 104(3):337-45. PubMed ID: 19122176
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast growth factor-2 is required for vasa vasorum plexus stability in hypercholesterolemic mice.
Mollmark JI; Park AJ; Kim J; Wang TZ; Katzenell S; Shipman SL; Zagorchev LG; Simons M; Mulligan-Kehoe MJ
Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2644-51. PubMed ID: 22982464
[TBL] [Abstract][Full Text] [Related]
3. Antiangiogenic activity of rPAI-1(23) promotes vasa vasorum regression in hypercholesterolemic mice through a plasmin-dependent mechanism.
Mollmark J; Ravi S; Sun B; Shipman S; Buitendijk M; Simons M; Mulligan-Kehoe MJ
Circ Res; 2011 Jun; 108(12):1419-28. PubMed ID: 21546607
[TBL] [Abstract][Full Text] [Related]
4. Anti-angiogenic activity of rPAI-1(23) and vasa vasorum regression.
Mulligan-Kehoe MJ
Trends Cardiovasc Med; 2013 May; 23(4):114-20. PubMed ID: 23313168
[TBL] [Abstract][Full Text] [Related]
5. Vasa vasorum anti-angiogenesis through H₂O₂, HIF-1α, NF-κB, and iNOS inhibition by mangosteen pericarp ethanolic extract (Garcinia mangostana Linn) in hypercholesterol-diet-given Rattus norvegicus Wistar strain.
Wihastuti TA; Sargowo D; Tjokroprawiro A; Permatasari N; Widodo MA; Soeharto S
Vasc Health Risk Manag; 2014; 10():523-31. PubMed ID: 25187725
[TBL] [Abstract][Full Text] [Related]
6. Plaque-associated vasa vasorum in aged apolipoprotein E-deficient mice exhibit proatherogenic functional features in vivo.
Rademakers T; Douma K; Hackeng TM; Post MJ; Sluimer JC; Daemen MJ; Biessen EA; Heeneman S; van Zandvoort MA
Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):249-56. PubMed ID: 23241413
[TBL] [Abstract][Full Text] [Related]
7. Adventitial fibroblast-derived vascular endothelial growth factor promotes vasa vasorum-associated neointima formation and macrophage recruitment.
Li XD; Hong MN; Chen J; Lu YY; Ye MQ; Ma Y; Zhu DL; Gao PJ
Cardiovasc Res; 2020 Mar; 116(3):708-720. PubMed ID: 31241138
[TBL] [Abstract][Full Text] [Related]
8. Angiogenesis Inhibitor, Endostar, Prevents Vasa Vasorum Neovascularization in a Swine Atherosclerosis Model.
Xu X; Mao W; Chai Y; Dai J; Chen Q; Wang L; Zhuang Q; Pan Y; Chen M; Ni G; Huang Z
J Atheroscler Thromb; 2015; 22(10):1100-12. PubMed ID: 26016418
[TBL] [Abstract][Full Text] [Related]
9. The anti-angiogenic activity of rPAI-1(23) inhibits fibroblast growth factor-2 functions.
Drinane M; Walsh J; Mollmark J; Simons M; Mulligan-Kehoe MJ
J Biol Chem; 2006 Nov; 281(44):33336-44. PubMed ID: 16950776
[TBL] [Abstract][Full Text] [Related]
10. Experimental hypercholesterolemia differentially affects adventitial vasa vasorum and vessel structure of the left internal thoracic and coronary arteries.
Galili O; Sattler KJ; Herrmann J; Woodrum J; Olson M; Lerman LO; Lerman A
J Thorac Cardiovasc Surg; 2005 Apr; 129(4):767-72. PubMed ID: 15821642
[TBL] [Abstract][Full Text] [Related]
11. Tongxinluo mitigates atherogenesis by regulating angiogenic factors and inhibiting vasa vasorum neovascularization in apolipoprotein E-deficient mice.
Ma L; Ni M; Hao P; Lu H; Yang X; Xu X; Zhang C; Huang S; Zhao Y; Liu X; Zhang Y
Oncotarget; 2016 Mar; 7(13):16194-204. PubMed ID: 26908443
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis.
Moulton KS; Vakili K; Zurakowski D; Soliman M; Butterfield C; Sylvin E; Lo KM; Gillies S; Javaherian K; Folkman J
Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4736-41. PubMed ID: 12682294
[TBL] [Abstract][Full Text] [Related]
13. Reduction in Vasa Vasorum Angiogenesis by Lp-PLA2 Selective Inhibitor Through The HIF-1α and VEGF Expression Under Dyslipidemic Conditions in Atherosclerosis Pathogenesis.
Heriansyah T; Nafisatuzzamrudah N; Aini FN; Ridwan M; Primardhika RF; Wijayanti M; Bekti RS; Wihastuti TA
Cardiovasc Hematol Agents Med Chem; 2018; 16(2):114-119. PubMed ID: 30394217
[TBL] [Abstract][Full Text] [Related]
14. Hyperglycaemia is associated with impaired vasa vasorum neovascularization and accelerated atherosclerosis in apolipoprotein-E deficient mice.
Veerman KJ; Venegas-Pino DE; Shi Y; Khan MI; Gerstein HC; Werstuck GH
Atherosclerosis; 2013 Apr; 227(2):250-8. PubMed ID: 23411040
[TBL] [Abstract][Full Text] [Related]
15. Quantification of plaque neovascularization using contrast ultrasound: a histologic validation.
Moguillansky D; Leng X; Carson A; Lavery L; Schwartz A; Chen X; Villanueva FS
Eur Heart J; 2011 Mar; 32(5):646-53. PubMed ID: 20581005
[TBL] [Abstract][Full Text] [Related]
16. Targeting vasa vasorum dysfunction to prevent atherosclerosis.
Boyle EC; Sedding DG; Haverich A
Vascul Pharmacol; 2017 Sep; 96-98():5-10. PubMed ID: 28830735
[TBL] [Abstract][Full Text] [Related]
17. Enhanced coronary vasa vasorum neovascularization in experimental hypercholesterolemia.
Kwon HM; Sangiorgi G; Ritman EL; McKenna C; Holmes DR; Schwartz RS; Lerman A
J Clin Invest; 1998 Apr; 101(8):1551-6. PubMed ID: 9541483
[TBL] [Abstract][Full Text] [Related]
18. Pericyte-specific deletion of ninjurin-1 induces fragile vasa vasorum formation and enhances intimal hyperplasia of injured vasculature.
Horiuchi K; Kano K; Minoshima A; Hayasaka T; Yamauchi A; Tatsukawa T; Matsuo R; Yoshida Y; Tomita Y; Kabara M; Nakagawa N; Takehara N; Hasebe N; Kawabe JI
Am J Physiol Heart Circ Physiol; 2021 Jun; 320(6):H2438-H2447. PubMed ID: 33961504
[TBL] [Abstract][Full Text] [Related]
19. Prevention of vasa vasorum neovascularization attenuates early neointima formation in experimental hypercholesterolemia.
Gössl M; Herrmann J; Tang H; Versari D; Galili O; Mannheim D; Rajkumar SV; Lerman LO; Lerman A
Basic Res Cardiol; 2009 Nov; 104(6):695-706. PubMed ID: 19458984
[TBL] [Abstract][Full Text] [Related]
20. Chronic endothelin receptor antagonism prevents coronary vasa vasorum neovascularization in experimental hypercholesterolemia.
Herrmann J; Best PJ; Ritman EL; Holmes DR; Lerman LO; Lerman A
J Am Coll Cardiol; 2002 May; 39(9):1555-61. PubMed ID: 11985922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
